ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1464

The Oral Microbiome as a Risk Factor for Benign or Pathologic Autoimmunity Associated with Anti-SSA/Ro Positivity and Mimicry for Von Willebrand Factor Type a Domain Protein (vWFA) of L. Mirabilis

Robert Clancy1, Miranda Marion 2, Peter Izmirly 1, Hannah Ainsworth 3, Timothy Howard 3, Mala Masson 1, Jill Buyon 1 and Carl Langefeld 3, 1NYU School of Medicine, New York, 2Wake Forest School of Medicine, Winston-Salem, NC, 3Wake Forest School of Medicine, Winston-Salem

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: autoantibodies, microbiome, pathogenesis and Sjogren's syndrome

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: Sjögrenʼs Syndrome – Basic & Clinical Science Poster II

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Autoantibody production precedes SLE or SS by years, including anti-Ro. Anti-Ro+ mothers of children with congenital heart block (CHB) are a unique population at risk for pathologic autoimmunity, as many are asymptomatic (Asym/UAS) and become aware of autoantibodies due to fetal disease and yet have a 10-year progression rate to SS/SLE of 20%-30%. We hypothesized that variation in the oral microbiome correlates with transition to SLE or SS and pathogenicity involves sequence homology between Ro60 and bacterial von Willebrand factor type A domain protein (vWFA).

Methods: The oral microbiome of 25 anti-Ro+ mothers of CHB children (Asym/UAS, N=9; SS/SLE, N=16) and 7 healthy controls (HC) were processed using 16S ribosomal RNA sequencing. Analysis of variance methods compared the centered log ratio transformed relative abundances for 1) HC vs. anti-Ro+ mothers, and 2) assuming an ordering of severity from HC < Asym/UAS < SS/SLE. To adjust for multiple comparisons, a taxonomic stepdown method coupled with false discovery rate (FDR) was used. The Basic Local Alignment Search Tool evaluated homology of Ro60 at aa 371-381 and peptides of vWFA.

Results: Sequencing 16S rRNA identified microorganisms from 2 kingdoms, 16 phyla, 25 classes, 41 orders, 70 families, 164 genera, and 166 species. The Shannon Index (H) revealed that for each taxonomic level except species, there were significant reductions in diversity in the anti-Ro+ mothers relative to HC (P ≤ 0.05). There were global differences in the microbiota of these mothers relative to HC (perMANOVA P=0.00049). The phylum Actinobacteria was more abundant in the anti-Ro+ mothers vs HC (PFDR=0.0231).  Within Actinobacteria, the class Coriobacteriia and subsequent lower taxonomic levels down to Atopobium parvulum, all exhibited increases in relative abundance in the anti-Ro+ mothers compared to HC. There was a significant reduction in the relative abundance as clinical severity increased within one of the most frequent phyla, Proteobacteria (PFDR=0.030; mean±SD; HC 0.24±0.07; Asym/UAS 0.19±0.12; SS/SLE 0.11±0.08). The difference in the relative abundances between Asym/UAS and SS/SLE within Proteobacteria was significant (P=0.042). Within Proteobacteria, the common class Betaproteobacteria also showed reduced relative abundance with increasing clinical severity (PFDR=0.0037; HC 0.11±0.04; Asym/UAS 0.072±0.07; SS/SLE 0.031±0.04). These ordered differences were maintained down the taxonomic hierarchy to the genus (Lautropia, PFDR=0.0072) and species within this genus (L. mirabilis, PFDR=0.012). Next, sequences of vWFA secreted by these taxa were evaluated.  For a comparison of Ro60 T cell epitope, FLLAVDVSASMNQ, the vWFA, VLVVFDNSSSMTA vWFA of A. parvulum was not a fit due to the aromatic and polar aa at positions 5 and 9, respectively. In contrast, the vWFA of L. mirabilis, LLLLLDVSGSMAG, was identical at 7 of the first 11 aa.

Conclusion: These data provide evidence that the microbiome differs along a clinical spectrum of autoimmunity.  In part, the data reflect a path involving depletion of L. mirabilis, which is secondary to a pathologic role of anti-Ro along with an expansion of A. parvulum, an opportunistic taxon.


Zenn_corrected_2Jun19_1_BW

Figure 1. Sequence homology of human Ro60 and peptides found in bacterial vWFA -upper panel- and associations of targeted taxa and anti-Ro+ mothers vs controls -lower panel-. For the former, note that Ro60 shares seven of its first 11 aa with L. mirabilis vWFA, while it shares only five with A. parvulum vWFA -sharing denoted by yellow and disharmony by red-. For the latter, note the depletion of L mirabilis, possibly occurring secondary to a pathologic role of anti-Ro along with an expansion of A. parvulum, an opportunistic taxon.


Disclosure: R. Clancy, Bristol Myers Squibb, 5, Exagen Diagnostics, 2; M. Marion, None; P. Izmirly, GlaxoSmithKline, 5; H. Ainsworth, None; T. Howard, None; M. Masson, None; J. Buyon, Bristol Myers Squibb, 5, Exagen Diagnostics, 2; C. Langefeld, None.

To cite this abstract in AMA style:

Clancy R, Marion M, Izmirly P, Ainsworth H, Howard T, Masson M, Buyon J, Langefeld C. The Oral Microbiome as a Risk Factor for Benign or Pathologic Autoimmunity Associated with Anti-SSA/Ro Positivity and Mimicry for Von Willebrand Factor Type a Domain Protein (vWFA) of L. Mirabilis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/the-oral-microbiome-as-a-risk-factor-for-benign-or-pathologic-autoimmunity-associated-with-anti-ssa-ro-positivity-and-mimicry-for-von-willebrand-factor-type-a-domain-protein-vwfa-of-l-mirabilis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-oral-microbiome-as-a-risk-factor-for-benign-or-pathologic-autoimmunity-associated-with-anti-ssa-ro-positivity-and-mimicry-for-von-willebrand-factor-type-a-domain-protein-vwfa-of-l-mirabilis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology